“ Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival: Aberrant T markers on malignant plasma cells”, Mediterr J Hematol Infect Dis, vol. 13, no. 1, p. e2021043, Jun. 2021, doi: 10.4084/MJHID.2021.043.